Tech investing is already wild. Abandoning quarterly reports could make it even wilder Less frequent reporting by public companies could mean better long-term decision-making, or more wild speculation—or both. Fortune · Sep 17, 2025
Neuralink Patient Met Musk Via FaceTime After Surgery — Says Billionaire Was Chill and 'Cool as Hell' Noland Arbaugh, paralysed since a 2016 accident, received a Neuralink brain implant in January 2024. The device allows him to control a computer cursor with his thoughts, transforming his life. International Business Times UK · Sep 16, 2025
The first person to get a Neuralink chip in his brain says he met Elon Musk on the day of his surgery: 'He's a cool dude' The 31-year-old Neuralink brain-computer interface recipient says he and Musk later discussed SpaceX and had an "alien talk." Fortune · Sep 16, 2025
Social media could use more moderation Social media platforms are pushing violent content to us—even when we're unprepared to see it. Fortune · Sep 16, 2025
Diaspora Co. raised capital only from angel investors Diaspora Co. sells high-quality spices sourced from southeast Asia. Fortune · Jul 7, 2025
Elon Musk’s business empire is taking over a small Texan town. Not all of its residents are pleased How Bastrop, pop. 12,000, became a magnet for a handful of Musk companies. Fortune · Nov 18, 2024
Behind the curtain of Joshua Kushner’s venture empire How the Thrive Capital founder approached his OpenAI investment. Fortune · Nov 13, 2024
Mobility tech deal value was up 13.9% quarter over quarter, led by autonomous driving startups, according to PitchBook Q2 saw some green shoots for mobility tech as a sector, as VCs invested $6.7 billion in mobility tech, marking a 13.9% quarter-over-quarter increase in deal value, according to PitchBook. Fortune · Sep 16, 2024
Silicon Valley goes to war—with itself How did America's tech hub become a funhouse mirror version of the country's dysfunctional partisan politics? Fortune · Jul 29, 2024
As more and more weight-loss startups prescribe Ozempic and Wegovy, doctors say they’re making unproven claims Noom, Calibrate, and Embla tell customers they can stop taking GLP-1s and keep off the weight they’ve lost. Doctors and drug manufacturers disagree. Fortune · Jul 10, 2024
How GM's Cruise investment became a liability GM is trying to salvage its $10 billion investment in Cruise after a robotaxi dragged a woman for 20 feet last fall. Fortune · May 20, 2024
Why Carta’s public battle might be a private markets nightmare Carta’s latest scandal could be a turning point for the company—but its implications could ultimately be bigger than the embattled cap table unicorn. Fortune · Jan 9, 2024
A thank you to the Term Sheet community To the wonderful Term Sheet community: Thank you. Fortune · Oct 6, 2023
RECUR, once worth more than $300 million, is just the latest NFT venture to crash and burn The startup, which hosted the IP of large brands like Hello Kitty, Paramount Pictures, and Nickelodeon, cited “significant shifts in the business landscape.” Fortune · Aug 24, 2023
Fortune · Jul 13, 2023 Al Gore uses a Hiroshima analogy to explain why every day feels like a ‘nature hike through the book of Revelation’ Former U.S. Vice President Al Gore used a sobering analogy to explain why climate change is driving natural disasters around the world.
Fortune · Jul 7, 2023 The Term Sheet monthly wrap: Biggest deals, funding rounds, and top stories for June 2023 A precarious dealmaking environment, A.I. deal count is down, and June’s most noteworthy VC deals.
Fortune · Jun 2, 2023 The Term Sheet monthly wrap: Biggest deals, funding rounds, and top stories A.I. breaks out, a founder turns the table on VCs, and May’s most noteworthy VC deals.
Fortune · Mar 22, 2023 How drone company Zipline turned one country’s logistical nightmare into a foundation for success The world's largest commercial drone delivery system launched by delivering blood to hospitals around Rwanda.